Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

Edit Content

    Development

    • Home
    • Development
    Close-up of the objective lenses of a microscope, showing three metal lenses labeled with magnification levels above a microscope stage—a vital tool in research supported by the Synovial Sarcoma Foundation.
    CHOP, Development, Dr. Theodore Laetsch, Research

    Synovial Sarcoma Foundation Celebrates Groundbreaking Achievement by Rachel Dr. Hurly

    June 3, 2025 joshs Comments Off on Synovial Sarcoma Foundation Celebrates Groundbreaking Achievement by Rachel Dr. Hurly

    The Synovial Sarcoma Foundation is proud to announce a significant milestone in pediatric cancer research: Dr. Rachel Hurly, a dedicated pediatric oncology fellow from the Children’s Hospital of Philadelphia (CHOP), has been honored with the prestigious American Society of Clinical Oncology (ASCO) Young Investigator Award. Dr. Hurly conducts her research under the mentorship of Dr. Ted Laetsch at the Haldor Laboratory at the University of Pennsylvania, with support from the Synovial Sarcoma Fund.

    The Synovial Sarcoma Foundation Surpasses $2 Million in Research Funding
    Development, Research

    The Synovial Sarcoma Foundation Surpasses $2 Million in Research Funding

    February 26, 2025 joshs Comments Off on The Synovial Sarcoma Foundation Surpasses $2 Million in Research Funding

    Thanks to the generosity of donors and supporters, the Fund has now raised over $2 million, accelerating research initiatives at CHOP and Penn Medicine. These funds are driving critical advancements in patient care, clinical trials, and the development of future treatment strategies. This milestone represents a major step forward in expanding Synovial Sarcoma research, allowing […]

    Search

    Categories

    • Black Flag Racing (2)
    • Case Study (1)
    • Children (1)
    • CHOP (3)
    • Development (2)
    • Dr. Theodore Laetsch (3)
    • Education (4)
    • Healthcare (3)
    • Latest News (7)
    • Research (13)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (3)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • Black and white photo of a baby's legs and feet resting on a soft blanket, with the focus on the feet and toes. The background and upper body are blurred.
      Synovial Sarcoma of the Parotid Gland in Infancy: A Rare Case Study
    • Two surgeons wearing surgical masks and caps focus intently on a procedure under bright operating room lights, with another medical professional visible in the background.
      Monophasic Synovial Sarcoma of the Posterior Pharyngeal Wall: A Rare Case Study
    • A gloved hand holds a clear petri dish near a microscope in a bright laboratory setting, suggesting scientific research or experiment.
      UI Health Care Begins Treating Patients With TCR Therapy for Synovial Sarcoma

    Tags

    Black Flag Racing Brigham and Women’s Hospital Callan Spence cancer-testis antigen Cancer Research Case Study Chase Spence Chas Spence CHOP Community Engagement & Partnerships Manager Dr. Rachel Hurly Dr. Ted Laetsch fibroblast fibroblast epigenome ground breaking human cell therapy immune-cell therapy Infant innovate treaments JAMA Internal Medicine Julie Kramer MAGE-A4 Monophasic Synovial Sarcoma Nathan Imperiale National Tumor Board Nature Communications Parotid Gland Patient Stories Pediatric Oncology Penn Medicine Penn Medicine Synovial Sarcoma Foundation Prasterone Rare Cancer rare disease research Sarcoma Synovial Sarcoma Synovial Sarcoma Foundation synovial sarcoma survivor synovial sarcoma treatment TCR-NK TCR Therapy TECELRA Zelluna ZI-MA4-1

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch